| Company Name: |
TargetMol
|
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
| Products Intro: |
Product Name:CLZX-205 CAS:3033694-01-5 Package:50mg;10mg
|
|
| | Methanone, (hexahydro-4-methyl-1H-1,4-diazepin-1-yl)[2-[[4-[1-(1-methylethyl)-1H-benzotriazol-6-yl]-2-pyridinyl]amino]-4-pyridinyl]- Basic information |
| | Methanone, (hexahydro-4-methyl-1H-1,4-diazepin-1-yl)[2-[[4-[1-(1-methylethyl)-1H-benzotriazol-6-yl]-2-pyridinyl]amino]-4-pyridinyl]- Chemical Properties |
| Boiling point | 679.8±55.0 °C(predicted) | | density | 1.31±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 8.06±0.10(predicted) |
| | Methanone, (hexahydro-4-methyl-1H-1,4-diazepin-1-yl)[2-[[4-[1-(1-methylethyl)-1H-benzotriazol-6-yl]-2-pyridinyl]amino]-4-pyridinyl]- Usage And Synthesis |
| Uses | CLZX-205 (compound C-7) is a selective inhibitor of CDK9, with the IC50 of 2.9 nM. CLZX-205 plays an important role in cancer research[1]. | | IC 50 | CDK9: 2.9 nM (IC50) | | References | [1] Ye Zhong, et al. Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and Biological Activity Evaluation. J Med Chem. 2024 Mar 28;67(6):4739-4756. DOI:10.1021/acs.jmedchem.3c02329 |
| | Methanone, (hexahydro-4-methyl-1H-1,4-diazepin-1-yl)[2-[[4-[1-(1-methylethyl)-1H-benzotriazol-6-yl]-2-pyridinyl]amino]-4-pyridinyl]- Preparation Products And Raw materials |
|